119 related articles for article (PubMed ID: 7226572)
1. Two new dopamine agonists that are long acting in vivo but short acting in vitro.
Grossman A; Yeo T; Delitala G; Hathway NR; Besser GM
Clin Endocrinol (Oxf); 1980 Dec; 13(6):595-9. PubMed ID: 7226572
[TBL] [Abstract][Full Text] [Related]
2. Pergolide, a potent long-acting dopamine-receptor agonist.
Lemberger L; Crabtree R; Callaghan JT
Clin Pharmacol Ther; 1980 May; 27(5):642-51. PubMed ID: 7189453
[TBL] [Abstract][Full Text] [Related]
3. Prolactin secretion inhibition by a new 8alpha-amino-ergoline, CH 29-171.
Flückiger E; Briner U; Doepfner W; Kovacs E; Marbach P; Wagner HR
Experientia; 1978 Oct; 34(10):1330-2. PubMed ID: 570121
[No Abstract] [Full Text] [Related]
4. The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells.
Yeo T; Thorner MO; Jones A; Lowry PJ; Besser GM
Clin Endocrinol (Oxf); 1979 Feb; 10(2):123-30. PubMed ID: 34491
[TBL] [Abstract][Full Text] [Related]
5. Dopamine receptor affinities in vitro and stereotypic activities in vivo of cabergoline in rats.
Miyagi M; Itoh F; Taya F; Arai N; Isaji M; Kojima M; Ujiie A
Biol Pharm Bull; 1996 Sep; 19(9):1210-3. PubMed ID: 8889042
[TBL] [Abstract][Full Text] [Related]
6. Potent 48 hours inhibition of prolactin secretion by pergolide in hyperprolactinaemic women.
L'Hermite M; Debusschere P
Acta Endocrinol (Copenh); 1982 Dec; 101(4):481-3. PubMed ID: 7158225
[TBL] [Abstract][Full Text] [Related]
7. Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
Pisarek H; Stepien H; Pawlikowski M
Endocr Regul; 1992 Mar; 26(1):17-22. PubMed ID: 1421203
[TBL] [Abstract][Full Text] [Related]
8. Variability and selectivity of anterior pituitary response to dopamine agonists throughout the normal menstrual cycle.
Kletzky OA; Shangold GA
Am J Obstet Gynecol; 1986 Feb; 154(2):362-7. PubMed ID: 3080890
[TBL] [Abstract][Full Text] [Related]
9. The long-acting dopamine agonist pergolide mesylate for treatment of hyperprolactinaemia.
Bergh T; Nillius SJ; Wide L
Acta Eur Fertil; 1984; 15(6):421-4. PubMed ID: 6536135
[TBL] [Abstract][Full Text] [Related]
10. Pergolide and bromocriptine for the treatment of patients with hyperprolactinemia.
Kletzky OA; Borenstein R; Mileikowsky GN
Am J Obstet Gynecol; 1986 Feb; 154(2):431-5. PubMed ID: 3080892
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hyperprolactinaemia with pergolide mesylate: acute effects and preliminary evaluation of long-term treatment.
Franks S; Horrocks PM; Lynch SS; Butt WR; London DR
Lancet; 1981 Sep; 2(8248):659-61. PubMed ID: 6116045
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine and alpha-ergocryptine do not inhibit oxytocin secretion in the lactating rat.
Russell JA; Harrison DJ; McNeilly AS
J Endocrinol; 1981 Apr; 89(1):91-8. PubMed ID: 6894307
[TBL] [Abstract][Full Text] [Related]
13. The effect of mesulergine on prolactin secretion and anterior pituitary cells morphology in diethylstilboestrol-treated female Wistar rats.
Pisarek H; Stepien H
Histol Histopathol; 1992 Jan; 7(1):111-7. PubMed ID: 1576426
[TBL] [Abstract][Full Text] [Related]
14. Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes.
Ohta K; Kuno S; Mizuta I; Fujinami A; Matsui H; Ohta M
Life Sci; 2003 Jun; 73(5):617-26. PubMed ID: 12770616
[TBL] [Abstract][Full Text] [Related]
15. Interaction of sulfpride and ergot derivatives on rat brain DOPAC concentration and prolactin secretion in vivo.
Hofmann M; Battaini F; Tonon G; Trabucchi M; Spano P
Eur J Pharmacol; 1979 Jun; 56(1-2):15-20. PubMed ID: 467503
[TBL] [Abstract][Full Text] [Related]
16. Discordant responses of prolactinoma to two different dopamine agonists.
Ahmed SR; Shalet SM
Clin Endocrinol (Oxf); 1986 Apr; 24(4):421-6. PubMed ID: 3742834
[TBL] [Abstract][Full Text] [Related]
17. The effect of 2-bromo-alpha-ergocryptine and 2-chloro-alpha-methylergoline-8beta-acetonitrile (lergotrile mesylate) on the prolactin secretion of the ewe.
Hooley RD; Fell LR; Findlay JK
Acta Endocrinol (Copenh); 1977 Dec; 86(4):722-7. PubMed ID: 411304
[TBL] [Abstract][Full Text] [Related]
18. Effect of bromocriptine and pergolide on pituitary tumor size and serum prolactin.
Horowitz BL; Hamilton DJ; Sommers CJ; Bryan RN; Boyd AE
AJNR Am J Neuroradiol; 1983; 4(3):415-7. PubMed ID: 6410759
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of pergolide mesylate in long term treatment of hyperprolactinaemia.
Franks S; Horrocks PM; Lynch SS; Butt WR; London DR
Br Med J (Clin Res Ed); 1983 Apr; 286(6372):1177-9. PubMed ID: 6404378
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic effects in man of a potent, long-acting dopamine receptor agonist.
Lemberger L; Crabtree RE
Science; 1979 Sep; 205(4411):1151-3. PubMed ID: 382359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
